Analysis of expression of the PD-1/PD-L1 immune checkpoint system and its prognostic impact in gastroenteropancreatic neuroendocrine tumors

The immune checkpoint based therapy targeting the programmed death-1 (PD-1) receptor and its PD-L1 ligand has recently been approved for the therapy of different malignant conditions, but not yet for gastroenteropancreatic neuroendocrine tumors (GEP-NETs). In this context, we evaluated the expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Sampedro-Núñez, Miguel, Serrano-Somavilla, Ana, Adrados, Magdalena, Cameselle-Teijeiro, José M., Blanco-Carrera, Concepción, Cabezas-Agricola, José Manuel, Martínez-Hernández, Rebeca, Martín-Pérez, Elena, Muñoz de Nova, José Luis, Díaz, José Ángel, García-Centeno, Rogelio, Caneiro-Gómez, Javier, Abdulkader, Ihab, González-Amaro, Roberto, Marazuela, Mónica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292913/
https://www.ncbi.nlm.nih.gov/pubmed/30546030
http://dx.doi.org/10.1038/s41598-018-36129-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292913/
https://www.ncbi.nlm.nih.gov/pubmed/30546030
http://dx.doi.org/10.1038/s41598-018-36129-1

Ejemplares similares